|
Article Excerpt
ImmuneRegen(r) BioSciences, Inc., Scottsdale, Ariz., a wholly owned biotechnology product development and licensing subsidiary of IR BioSciences Holdings, Inc. (OTCBB:IRBO), has commenced a collaboration with DelSite Biotechnologies, Inc., a wholly owned subsidiary of Carrington Laboratories (CARN.OB), to develop a new vaccine adjuvant system that provides both immediate and sustained immunostimulation for more effective protection against a variety of transmittable pathogens.
With an initial focus on an influenza virus vaccine, the collaboration will determine if the combination of ImmuneRegen's vaccine adjuvant compound, Viprovex(r), and DelSite's unique adjuvant system, based on the polymer GelSite(r), can potentially augment the ability of vaccine products to produce the enhanced immune response. Viprovex, a formulation of ImmuneRegen's Homspera(tm), has previously shown vaccine adjuvant activity in...
|
|
More articles from Biotech Business
WEILL CORNELL INDENTIFIES NEW FORM OF INHERITED CANCER RISK., May 01, 2008
THE GI COMPANY TO PRESENT PHASE II ORAL MUCOSITIS DATA AT ASCO., May 01, 2008
OXIGENE BEGINS PHASE II NSCLC TRIAL OF ZYBRESTAT WITH CHEMOTHERAPY., May 01, 2008
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
